# Hetero Labs Ltd. Unit VI – FDA Inspection, Sep 21, 2023

Source: https://www.keypedia.com/records/fda_inspections/hetero-labs-ltd-unit-vi/4d20198b-8e22-4196-b631-b4835f9009f5
Source feed: FDA_Inspections

> FDA inspection 1218220 of Hetero Labs Ltd. Unit VI, September 21, 2023. Classification: Voluntary Action Indicated (VAI). 8 citations under 21 CFR part 211. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1218220
- Company Name: Hetero Labs Ltd. Unit VI
- Inspection Date: 2023-09-21
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 8

## Related Documents

- [FDA Inspection 999209 - 2016-11-15](https://www.keypedia.com/records/fda_inspections/hetero-labs-ltd-unit-vi/4427e13b-4ca3-4730-b696-ef5df9aee016)
- FDA Inspection 833134 - 2013-05-23

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/brandy-n-lepage/41e679e3-cc2a-4361-bf89-26acbd7deaf8)
- [FDA Associated Person](https://www.keypedia.com/people/jennifer-l-huntington/c04e1c86-c7ec-4613-b3f7-a1f9ba2b2f2c)

Company: https://www.keypedia.com/companies/hetero-labs-ltd-unit-vi/e83c840a-da16-4087-9b97-86544ffddaeb

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c